v3.26.3
Stockholders' Equity (Deficit)
 9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Stockholders' Equity (Deficit) . Stockholders’ Equity (Deficit)

2024 Stock Repurchase Program

On February 6, 2024, the Board of Directors authorized the repurchase of up to $50.0 million of shares of the Company’s common stock through March 1, 2026. The program expired on March 1, 2026, and no shares were repurchased during the nine months ended September 30, 2026. Over the life of the program, the Company repurchased 15,448,533 shares for an aggregate of $40.5 million.

Common Shares Reserved

As of September 30, 2026, the Company had reserved shares of common stock for future issuance under equity compensation plans as follows (in thousands):

 

 

 

Securities To Be Issued Upon Exercise Of Options

 

 

Securities To Be Issued Upon Release Of Restricted Stock

 

 

Number Of Remaining Securities Available For Future Issuance

 

2022 Inducement Equity Incentive Plan

 

 

6,795

 

 

 

112

 

 

 

1,095

 

2011 Equity Incentive Plan

 

 

15,901

 

 

 

15,359

 

 

 

23,812

 

2017 Inducement Award Plan

 

 

—

 

 

 

—

 

 

 

61

 

2017 Employee Stock Purchase Plan

 

 

—

 

 

 

—

 

 

 

1,543

 

SomaLogic Plans

 

 

10,344

 

 

 

23

 

 

 

—

 

Total common stock reserved for future issuance

 

 

33,040

 

 

 

15,494

 

 

 

26,511